CAA 2022 Prescription Drug Data Collection (RxDC)
On May 24, 2023, PharmAvail successfully submitted 2022 Reference Year data in accordance with the Consolidated Appropriations Act, 2021 (CAA) ahead of the June 1 deadline.
Curious how we are handling reporting for 2023? Read on for more information.
Per the requirements of the Consolidated Appropriations Act, 2021 (CAA) in Division BB, Title II, Part E, Section 204 of the CAA, 2021, “Required Reporting on Pharmacy Benefits and Drug Costs,” PharmAvail will submit Section 204 Reporting for required plans no later than June 1, 2024.
Who does this impact? Reporting is required for all health insurance issuers and fully-insured and self-funded group health plans, including grandfathered plans.
What timeframe is reported? 2023
When is the reporting deadline? June 1, 2024
PharmAvail will submit data for all impacted clients, active or termed, that had claims within the reporting period. PharmAvail continues to provide this reporting free of charge to our clients. If you were an PharmAvail client for only part of the reporting period, please contact your broker, third party administrator (TPA), or other PBM to ensure that data for those reporting periods will be submitted.
PharmAvail will submit the following reports in aggregate on the client’s behalf:
While much of the data that must be submitted is related to the pharmacy benefit, some of it is not. Please contact your broker or TPA to ensure that the following reports are being filed on your behalf.